Immix Biopharma, Inc. (IMMX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 92.27M | 101.24M | 16.58M | 12.33M | 16.78M | 20.2M | 22.76M | 27.33M | 32.92M | 19.79M | 22.33M | 15.51M | 13.03M | 14.9M | 17.39M | 19.08M | 20.01M | 18.19M | 242.92K | 291.97K |
| Cash & Short-Term Investments | 90.58M | 100.41M | 15.95M | 11.64M | 15.92M | 17.68M | 19.69M | 23.98M | 29.32M | 17.51M | 19.58M | 12.65M | 11.46M | 13.44M | 16.92M | 18.4M | 19.06M | 17.64M | 37.99K | 110.6K |
| Cash Only | 79.25M | 93.93M | 15.95M | 11.64M | 15.92M | 17.68M | 19.69M | 23.98M | 29.32M | 17.51M | 19.58M | 12.65M | 11.46M | 13.44M | 16.92M | 18.4M | 19.06M | 17.64M | 37.99K | 110.6K |
| Short-Term Investments | 11.33M | 6.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 1.97M | 1.98M | 1.98M | 2.02M | 1.17M | 652.48K | 297K | 322.38K | 255.71K | 182.34K | 165.05K | 63.73K | 25.72K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.7M | 828.33K | 132.76K | 137.7K | 168.4K | 32.27K | 36.52K | 105.78K | 175.25K | 44.58K | 167K | 2.56M | 1.25M | 78.07K | 0 | 0 | 888.01K | 0 | 188.63K | 174.33K |
| Total Non-Current Assets | 3.54M | 3.6M | 3.5M | 3.31M | 3.11M | 2.75M | 2.39M | 1.51M | 1.43M | 137.41K | 143.27K | 59.27K | 178.19K | 10.28K | 4.13K | 4.69K | 5.08K | 5.7K | 252.34K | 59.61K |
| Property, Plant & Equipment | 3.36M | 3.49M | 3.36M | 3.18M | 3.09M | 2.73M | 2.37M | 1.48M | 1.41M | 50.18K | 40.08K | 2.55K | 3.06K | 3.56K | 4.13K | 4.69K | 5.08K | 5.7K | 6.32K | 6.93K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 185.14K | 114.05K | 132.11K | 131.02K | 20.42K | 20.42K | 20.42K | 20.42K | 20.42K | 87.23K | 103.19K | 56.72K | 175.13K | 6.72K | 0 | 0 | 0 | 0 | 246.02K | 52.67K |
| Total Assets | 95.82M | 104.84M | 20.08M | 15.64M | 19.89M | 22.95M | 25.14M | 28.84M | 34.35M | 19.93M | 22.47M | 15.57M | 13.21M | 14.91M | 17.4M | 19.09M | 20.02M | 18.19M | 495.26K | 351.58K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 381.68% | 356.86% | -20.13% | -45.78% | -42.09% | 15.17% | 11.87% | 85.24% | 159.98% | 33.65% | 29.2% | -18.45% | -34% | -18.05% | 3412.31% | 5329.19% | - | 3271.42% | - | - |
| Total Current Liabilities | 10.54M | 10.11M | 10.85M | 10.01M | 9.31M | 8.69M | 6.56M | 3.9M | 5.66M | 3.72M | 2.83M | 2.4M | 1.47M | 1.27M | 646.46K | 977.21K | 365.09K | 202.04K | 6.46M | 6M |
| Accounts Payable | 0 | 0 | 7.05M | 6.61M | 5.74M | 5.39M | 3.29M | 2.35M | 3.51M | 1.43M | 1.57M | 2.4M | 1.47M | 143.07K | 646.46K | 977.21K | 305.68K | 142.94K | 618.03K | 182.78K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 125.39K | 139.34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 50K | 4.1M | 4.1M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.41M | 9.97M | 438.24K | 0 | 731.79K | 658.16K | 198.09K | 170.63K | 577.02K | 0 | 1.13M | 0 | 0 | 0 | 0 | 0 | 9.41K | 0 | 1.31M | 1.31M |
| Current Ratio | 8.76x | 10.01x | 1.53x | 1.23x | 1.80x | 2.33x | 3.47x | 7.00x | 5.82x | 5.32x | 7.90x | 6.47x | 8.85x | 11.70x | 26.90x | 19.53x | 54.82x | 90.01x | 0.04x | 0.05x |
| Quick Ratio | 8.76x | 10.01x | 1.53x | 1.23x | 1.80x | 2.33x | 3.47x | 7.00x | 5.82x | 5.32x | 7.90x | 6.47x | 8.85x | 11.70x | 26.90x | 19.53x | 54.82x | 90.01x | 0.04x | 0.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 912.34K | 933.63K | 965.05K | 972.34K | 991.13K | 1.01M | 1.03M | 1.04M | 1.06M | 0 | 0 | 0 | 0 | 475K | 0 | 0 | 0 | 0 | 226.94K | 206.81K |
| Long-Term Debt | 912.34K | 933.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 146.94K | 126.81K |
| Capital Lease Obligations | 0 | 0 | 965.05K | 972.34K | 991.13K | 1.01M | 1.03M | 1.04M | 1.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 475K | 0 | 0 | 0 | 0 | 80K | 80K |
| Total Liabilities | 11.45M | 11.04M | 11.82M | 10.98M | 10.3M | 9.7M | 7.59M | 4.94M | 6.72M | 3.72M | 2.83M | 2.4M | 1.47M | 1.75M | 646.46K | 977.21K | 365.09K | 202.04K | 6.69M | 6.2M |
| Total Debt | 1.04M | 1.07M | 1.11M | 1.04M | 1.06M | 1.07M | 1.09M | 1.09M | 1.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 50K | 4.25M | 4.23M |
| Net Debt | -78.21M | -92.86M | -14.84M | -10.6M | -14.86M | -16.61M | -18.6M | -22.88M | -28.23M | -17.51M | -19.58M | -12.65M | -11.46M | -13.44M | -16.92M | -18.4M | -19.01M | -17.59M | 4.21M | 4.12M |
| Debt / Equity | 0.01x | 0.01x | 0.13x | 0.22x | 0.11x | 0.08x | 0.06x | 0.05x | 0.04x | - | - | - | - | - | - | - | 0.00x | 0.00x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -14320.68x | -3427.93x | -510.24x | -6.45x | -2.84x |
| Total Equity | 84.36M | 93.8M | 8.26M | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M | 27.63M | 16.2M | 19.65M | 13.17M | 11.74M | 13.16M | 16.75M | 18.11M | 19.65M | 17.99M | -6.2M | -5.85M |
| Equity Growth % | 779.38% | 607.83% | -52.91% | -80.52% | -65.28% | -18.22% | -10.68% | 81.4% | 135.39% | 23.13% | 17.32% | -27.28% | -40.27% | -26.85% | 370.33% | 409.55% | 515.43% | 480.29% | - | - |
| Book Value per Share | 2.20 | 2.45 | 0.26 | 0.16 | 0.32 | 0.48 | 0.60 | 0.83 | 1.18 | 0.81 | 1.06 | 0.88 | 0.84 | 0.99 | 1.20 | 1.30 | 1.42 | 2.37 | -0.86 | -0.67 |
| Total Shareholders' Equity | 84.36M | 93.8M | 8.26M | 4.65M | 9.59M | 13.25M | 17.55M | 23.89M | 27.92M | 16.41M | 19.77M | 13.23M | 11.77M | 13.16M | 16.75M | 18.11M | 19.65M | 17.99M | -6.2M | -5.85M |
| Common Stock | 5.31K | 5.3K | 3.31K | 2.85K | 2.79K | 2.76K | 2.76K | 2.75K | 2.65K | 2K | 1.97K | 1.63K | 1.4K | 1.4K | 1.4K | 1.4K | 1.39K | 1.32K | 338 | 338 |
| Retained Earnings | -114.55M | -104.46M | -93.78M | -86.19M | -79.57M | -75.02M | -70.21M | -63.06M | -58.67M | -53.41M | -48.32M | -44.04M | -40.46M | -37.99M | -34.19M | -32.65M | -31.09M | -29.76M | -7M | -6.6M |
| Treasury Stock | 0 | 0 | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -99.96K | -55.96K | -55.96K | 0 | 0 | 0 | 0 |
| Accumulated OCI | 105.64K | 60.16K | 62.46K | 65.03K | 15.46K | -1.06K | 192.05K | 116.97K | 89.61K | 134.67K | 46.73K | 80.88K | 82.55K | 87.02K | 62.05K | 102.44K | 141K | 125.41K | 123.87K | 127.39K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -283.28K | -201.74K | -124.67K | -56.77K | -32.36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |